Shopping Cart 0
Cart Subtotal
USD 0

Stellar Biotechnologies Inc (SBOT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injectable product to assess immune response. Its products comprise Stellar KLH protein which can be used in various grades, formulations, and configurations for both clinical and research applications and KLH Elisa Kits. Stellar Bio's products are used in immunotherapies as an immune stimulant in immunotoxicology applications and therapeutic vaccine conjugation. The company partners with research centers and developers of active immunotherapies and therapeutic vaccines. Stellar Bio is headquartered in Port Hueneme, California, the US.

Stellar Biotechnologies Inc (SBOT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Stellar Biotechnologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Stellar Biotech and Neovacs Form Joint Venture 12

Stellar Biotech Enters Into Co-Development Agreement With Amaran Biotech 13

Equity Offering 14

Stellar Biotech to Raise USD3 Million in Private Placement of Shares up on Exercise of Warrants 14

Stellar Biotech Raises USD5.5 Million in Public Offering of Units 15

Stellar Biotech Raises USD6.8 Million in Private Placement of Shares and Warrants 16

Stellar Biotechnologies Completes Second Tranche Private Placement Of Units For USD 12 Million 17

Stellar Biotechnologies Completes Second Tranche Of Private Placement Of Units For USD 5 Million 19

Stellar Biotechnologies Completes Private Placement Of Units For USD 1.6 Million 21

Stellar Biotech Completes Private Placement Of Units For USD 0.5 Million 22

Stellar Biotechnologies Completes Private Placement Of Units For USD 1 Million 23

Asset Transactions 24

Matrivax to Acquire Immunogen and Vaccine Technology from Stellar Biotech 24

Stellar Biotechnologies Inc-Key Competitors 25

Stellar Biotechnologies Inc-Key Employees 26

Stellar Biotechnologies Inc-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Joint Venture 27

Recent Developments 28

Financial Announcements 28

Aug 08, 2018: Stellar Biotechnologies reports third quarter financial results 28

May 07, 2018: Stellar Biotechnologies Announces Second Quarter Financial Results 30

Feb 07, 2018: Stellar Biotechnologies Reports First Quarter 2018 Financial Results 32

Dec 01, 2017: Stellar Biotechnologies Reports Fiscal Year 2017 Financial Results 33

Aug 09, 2017: Stellar Biotechnologies Reports Third Quarter 2017 Financial Results 34

May 09, 2017: Stellar Biotechnologies Reports Second Quarter 2017 Financial Results 36

Feb 06, 2017: Stellar Biotechnologies Reports First Quarter 2017 Financial Results 38

Corporate Communications 39

Jan 25, 2018: Stellar Biotechnologies Appoints Pharma Licensing Expert to Board of Directors 39

Product News 40

Jun 21, 2018: Stellar Reports Positive Research Results from KLH Glycosylation Study 40

Jan 11, 2017: Stellar Biotechnologies Advances Strategic Plan to Secure Key Production Region 41

Other Significant Developments 42

May 24, 2018: Stellar Achieves Robust Viral Clearance for Manufacturing Process 42

Mar 29, 2018: Stellar Biotech Begins Scale-Up and Expansion Project at Port Facility 43

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44


List Of Figure

List of Figures

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Stellar Biotechnologies Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Stellar Biotechnologies Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Stellar Biotechnologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Stellar Biotech and Neovacs Form Joint Venture 12

Stellar Biotech Enters Into Co-Development Agreement With Amaran Biotech 13

Stellar Biotech to Raise USD3 Million in Private Placement of Shares up on Exercise of Warrants 14

Stellar Biotech Raises USD5.5 Million in Public Offering of Units 15

Stellar Biotech Raises USD6.8 Million in Private Placement of Shares and Warrants 16

Stellar Biotechnologies Completes Second Tranche Private Placement Of Units For USD 12 Million 17

Stellar Biotechnologies Completes Second Tranche Of Private Placement Of Units For USD 5 Million 19

Stellar Biotechnologies Completes Private Placement Of Units For USD 1.6 Million 21

Stellar Biotech Completes Private Placement Of Units For USD 0.5 Million 22

Stellar Biotechnologies Completes Private Placement Of Units For USD 1 Million 23

Matrivax to Acquire Immunogen and Vaccine Technology from Stellar Biotech 24

Stellar Biotechnologies Inc, Key Competitors 25

Stellar Biotechnologies Inc, Key Employees 26

Stellar Biotechnologies Inc, Subsidiaries 27

Stellar Biotechnologies Inc, Joint Venture 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Stellar Biotechnologies Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injectable product to assess immune response. Its products comprise Stellar KLH protein which can be used in various grades, formulations, and configurations for both clinical and research applications and KLH Elisa Kits. Stellar Bio's products are used in immunotherapies as an immune stimulant in immunotoxicology applications and therapeutic vaccine conjugation. The company partners with research centers and developers of active immunotherapies and therapeutic vaccines. Stellar Bio is headquartered in Port Hueneme, California, the US.

Stellar Biotechnologies Inc (SBOT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Stellar Biotechnologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Stellar Biotech and Neovacs Form Joint Venture 12

Stellar Biotech Enters Into Co-Development Agreement With Amaran Biotech 13

Equity Offering 14

Stellar Biotech to Raise USD3 Million in Private Placement of Shares up on Exercise of Warrants 14

Stellar Biotech Raises USD5.5 Million in Public Offering of Units 15

Stellar Biotech Raises USD6.8 Million in Private Placement of Shares and Warrants 16

Stellar Biotechnologies Completes Second Tranche Private Placement Of Units For USD 12 Million 17

Stellar Biotechnologies Completes Second Tranche Of Private Placement Of Units For USD 5 Million 19

Stellar Biotechnologies Completes Private Placement Of Units For USD 1.6 Million 21

Stellar Biotech Completes Private Placement Of Units For USD 0.5 Million 22

Stellar Biotechnologies Completes Private Placement Of Units For USD 1 Million 23

Asset Transactions 24

Matrivax to Acquire Immunogen and Vaccine Technology from Stellar Biotech 24

Stellar Biotechnologies Inc-Key Competitors 25

Stellar Biotechnologies Inc-Key Employees 26

Stellar Biotechnologies Inc-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Joint Venture 27

Recent Developments 28

Financial Announcements 28

Aug 08, 2018: Stellar Biotechnologies reports third quarter financial results 28

May 07, 2018: Stellar Biotechnologies Announces Second Quarter Financial Results 30

Feb 07, 2018: Stellar Biotechnologies Reports First Quarter 2018 Financial Results 32

Dec 01, 2017: Stellar Biotechnologies Reports Fiscal Year 2017 Financial Results 33

Aug 09, 2017: Stellar Biotechnologies Reports Third Quarter 2017 Financial Results 34

May 09, 2017: Stellar Biotechnologies Reports Second Quarter 2017 Financial Results 36

Feb 06, 2017: Stellar Biotechnologies Reports First Quarter 2017 Financial Results 38

Corporate Communications 39

Jan 25, 2018: Stellar Biotechnologies Appoints Pharma Licensing Expert to Board of Directors 39

Product News 40

Jun 21, 2018: Stellar Reports Positive Research Results from KLH Glycosylation Study 40

Jan 11, 2017: Stellar Biotechnologies Advances Strategic Plan to Secure Key Production Region 41

Other Significant Developments 42

May 24, 2018: Stellar Achieves Robust Viral Clearance for Manufacturing Process 42

Mar 29, 2018: Stellar Biotech Begins Scale-Up and Expansion Project at Port Facility 43

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44


List Of Figure

List of Figures

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Stellar Biotechnologies Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Stellar Biotechnologies Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Stellar Biotechnologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

Stellar Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Stellar Biotech and Neovacs Form Joint Venture 12

Stellar Biotech Enters Into Co-Development Agreement With Amaran Biotech 13

Stellar Biotech to Raise USD3 Million in Private Placement of Shares up on Exercise of Warrants 14

Stellar Biotech Raises USD5.5 Million in Public Offering of Units 15

Stellar Biotech Raises USD6.8 Million in Private Placement of Shares and Warrants 16

Stellar Biotechnologies Completes Second Tranche Private Placement Of Units For USD 12 Million 17

Stellar Biotechnologies Completes Second Tranche Of Private Placement Of Units For USD 5 Million 19

Stellar Biotechnologies Completes Private Placement Of Units For USD 1.6 Million 21

Stellar Biotech Completes Private Placement Of Units For USD 0.5 Million 22

Stellar Biotechnologies Completes Private Placement Of Units For USD 1 Million 23

Matrivax to Acquire Immunogen and Vaccine Technology from Stellar Biotech 24

Stellar Biotechnologies Inc, Key Competitors 25

Stellar Biotechnologies Inc, Key Employees 26

Stellar Biotechnologies Inc, Subsidiaries 27

Stellar Biotechnologies Inc, Joint Venture 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Stellar Biotechnologies Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.